Sun Pharmaceutical Industries Limited

NSE:SUNPHARMA.NS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

India

Market Cap

USD 45.09 B

Share Price

USD 18.79

Avg Daily Volume

2,342,265

Change (1 day)

0.05%

Change (1 year)

-9.83%

Change (YTD)

-14.71%

Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2025: 28.99%

Sun Pharmaceutical Industries Limited EBITDA Margin is 28.99% for the year ending March 31, 2025, a 0.06% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2024 was 28.97%, a 3.75% change year over year.
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2023 was 27.92%, a 60.16% change year over year.
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2022 was 17.44%, a 15.59% change year over year.
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2021 was 15.08%, a -33.33% change year over year.